Illumina Inc. (ILMN) was reiterated an ‘Hold’ by Canaccord Genuity analysts on Wednesday. The broker however, cut its price target on the stock to $140 from $160 following last night’s earnings release. The San Diego, CA – based provider of solutions for genetic analysis handed in earnings of $0.71 per share on revenue of $571.8 […]
View the full post at: Wall Street Pit